Prospective Evaluation of the Cardiovascular Effects of BRAF and MEK Inhibitors in Patients With Melanoma.

Saved in:
Bibliographic Details
Title: Prospective Evaluation of the Cardiovascular Effects of BRAF and MEK Inhibitors in Patients With Melanoma.
Authors: Glen C; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, Scotland, United Kingdom., Dobbin SJH; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, Scotland, United Kingdom., Mangion K; Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow, Scotland, United Kingdom., Henderson A; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, Scotland, United Kingdom., Brooksbank K; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, Scotland, United Kingdom., Coats CJ; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, Scotland, United Kingdom., Epstein FH; School of Engineering and Applied Science, University of Virginia, Charlottesville, Virginia, USA., Kellman P; National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA., Butler E; University of Glasgow, Glasgow, Scotland, United Kingdom., Evans TRJ; Beatson West of Scotland Cancer Centre, NHS Greater Glasgow and Clyde, Glasgow, Scotland, United Kingdom; Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom., Jones R; Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom., McClure J; University of Glasgow, Glasgow, Scotland, United Kingdom., Roditi G; University of Glasgow, Glasgow, Scotland, United Kingdom., Tan YY; Beatson West of Scotland Cancer Centre, NHS Greater Glasgow and Clyde, Glasgow, Scotland, United Kingdom., Waterston A; Beatson West of Scotland Cancer Centre, NHS Greater Glasgow and Clyde, Glasgow, Scotland, United Kingdom., Welsh P; University of Glasgow, Glasgow, Scotland, United Kingdom., Petrie MC; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, Scotland, United Kingdom., Lang NN; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, Scotland, United Kingdom. Electronic address: ninian.lang@glasgow.ac.uk.
Source: JACC. CardioOncology [JACC CardioOncol] 2025 Dec; Vol. 7 (7), pp. 852-866. Date of Electronic Publication: 2025 Oct 10.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101761697 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-0873 (Electronic) Linking ISSN: 26660873 NLM ISO Abbreviation: JACC CardioOncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2666-0873
DOI:10.1016/j.jaccao.2025.08.006